This move aims to establish an indigenous supply, moving away from current imports and scaling up production to a mandated ...

Through cutting-edge methods and advanced artificial intelligence analysis, UNC Charlotte researchers leading a ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Every year, around 600 million people are struck down by foodborne illnesses. The culprits are often common yet dangerous bacteria, such as E. coli and Salmonella, that thrive in undercooked or ...

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...

After winning accolades in the US for his outstanding research, Xie’s work will continue to focus on effective mRNA-based ...

The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation ...

Lidia Morawska, an internationally renowned expert in air quality and its impact on human health, has won Australia's most coveted prize for scientific research.

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

EMA grants Orphan Drug Designation to Ribo’s siRNA therapeutic RBD1016 for Hepatitis Delta Virus infection: Beijing, China Saturday, October 25, 2025, 17:00 Hrs [IST] Suzhou Rib ...